Radiopharmaceuticals Startup Secures $175M Funding
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
- Latest
- Trending
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
Adobe beats Q3 expectations but shares fall 10% due to disappointing Q4 guidance, impacting investor sentiment.
UnityPoint Health-Grinnell introduces Neoprobe Gamma Detection for precise breast cancer surgery, enhancing patient care and personalized treatment.
iShares U.S. Technology ETF saw diverse changes in the 3rd quarter, with valuations reaching $90.72M and $2.45M amid varying percentage ...
A recent clinical trial in Japan reveals that virtual reality therapy can greatly improve the physical and emotional symptoms of ...
Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
Discover the game-changing role of Artificial Intelligence (AI) in the field of Radiology, enhancing patient care at Regional Medical Imaging ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.